that is not a secret.
why is it that AM spent millions on the study without have the ballllssss to stick an NDA under the FDAs nose and dare them to turn it down?
source of dd for you statement " strategic planning by competitors has aldox in the market by 2017" is what?
my call is that not a word during the mid year cc. am will avoid and no analyst will ask.
they need t o open the cc to shareholders to ask questions and leave the analysts out since the company has no earnings to speak of and review.
I am good all the way down to $5. you are either late to the party or a trader.
you recall the party UNA threw that served bacon wrapped SHRIMP. THAT WAS THE TIME TO LOAD THE BOAT.
J20 was filling his, as was Franco and others.
give it a rest.
do you actually own more than a few shares of cytr?
why are you here?
interesting thought, when would we expect to see interim data? i.e. at 50% of events if so when could that be, early 2016?
give it a rest.
do some dd on the science and share your findings, anything but the continuous dribble.
start a political rant, that would at least be amusing.
read the bylaws - two years to replace the BOARD. looks like Docs Patterson and Salkind are good with how things are going. together they could effect change if they so desired.
only way we see CEO out is if he dies or is thrown in jail.
take solace in knowing he has not sold a single share. and perhaps the recent lawsuits have him on a short leash
previous thread implied to expect news as an interim CC was not typical. well the mid year cc is typical, hence no reason to expect news.